Chronic hepatitis C: Early intervention

Hospital Practice

Volumn 33, Issue 6, 1998, Pages 101-114

  Koff, Raymond S ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b METROWEST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL RESPONSE MODIFIER; CONSENSUS INTERFERON; PROTEINASE INHIBITOR; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; THYMOSIN ALPHA1;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; UNITED STATES;

EID: 0032525360     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1998.11443707     Document Type: Article

References (10)

1. Bennett WG et al: Cost-effectiveness of a single course of interferon-alfa 2b In patients with histologically mild chronic hepatitis C. Ann Intern Med 127:855, 1997
2. Chemello L et al: Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C: The TriVeneto Viral Hepatitis Group. Hepatology 22:700, 1995
3. Chemello L et al: The effect of Interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 23:8, 1995
4. Keeffe EB, Hollinger FB: Therapy of hepatitis C: Consensus interferon trials. Hepatology 26 (Suppl 1):101S, 1997
5. Lai M-Y et al: Long-term efficacy of ribavirin plus interferon alpha in the treatment of chronic hepatitis C. Gastroenterology 111:1307, 1996
6. Kim WR et al: Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med 127:866, 1997
7. Marcellin P et al: Long term histological improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 127:875, 1997
8. Poynard T et al: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24:778, 1996
9. Reichard O et al: Randomised, double-blind, placebo-controlled trial of interferon alfa-2b with and without ribavirin for chronic hepatitis C: The Swedish Study Group. Lancet 351:83, 1998
10. von Weizsacker F et al: Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleptides. and dominant negative mutants. Hepatology 26:251, 1997